Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN67,9367,96-0,73
Msft7,63
Nokia4,3854,451,06
IBM-0,89
Mercedes-Benz Group AG52,6252,65-2,73
PFE-1,97
02.05.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 01.05.2025 21:59:42
GSK ADS-WI (NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
38,73 -2,82 -1,13 4 165 511
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 02.05.2025
Popis společnosti
Obecné informace
Název společnostiGSK plc (ADR)
TickerGSK
Kmenové akcie:ADR
RICGSK
ISIN-
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky30.09.2024
Počet zaměstnanců k 31.12.2023 70 212
Akcie v oběhu k 30.09.20244 080 000 000
MěnaGBP
Kontaktní informace
Ulice980 Great West Road
MěstoBRENTFORD
PSČTW8 9GS
ZeměUnited Kingdom
Kontatní osoba 
Funkce kontaktní osoby 
Telefon442 080 475 000
Fax442080477807

Business Summary: GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.
Financial Summary: BRIEF: For the nine months ended 30 September 2024, GSK plc (ADR) revenues increased 4% to L23.26B. Net income decreased 53% to L2.16B. Revenues reflect US segment increase of 5% to L12.06B, Rest of world segment increase of 6% to L6.29B, Europe segment remaining flat at L4.91B. Net income was offset by Other segment loss increase from L862M to L4.39B, Research and Development segment loss increase of 5% to L4.06B.
Odvětvová klasifikace
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICSBiological Product (except Diagnostic) Manufacturing
NAICSDrugs and Druggists' Sundries Merchant Wholesalers
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS2007Biological Product (exc Diagnostic) Mfg
NAICS2007Drugs and Druggists' Sundries Merchant Wholesalers
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
NAICS1997Biological Product (except Diagnostic) Manufacturing
NAICS1997Drug, Drug Proprietaries and Druggists' Sundries Wholesalers
SICPharmaceutical Preparations
SICPharmaceutical Preparations
SICCommercial Physical Research
SICBiological Prod's Not Diagnostic
SICDrugs/proprietaries/sundries



  • Poslední aktualizace: 02.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorEmma Walmsley5501.04.2017
Chief Financial Officer, Executive DirectorJulie Brown6201.05.202303.04.2023
President - Corporate DevelopmentDavid Redfern58
President - Global Supply ChainRegis Simard-01.09.2018
President - Global AffairsPhil Thomson-
Chief Executive Officer, ViiV Healthcare and President - GSK Global HealthDeborah Waterhouse-01.04.2017
Chief People OfficerDiana Conrad-01.01.2009
Senior Vice President, Group General Counsel, Legal and ComplianceJames Ford-01.01.2018
Senior Vice President - Global Communications and CEO OfficeSally Jackson55
Chief Digital and Technology OfficerShobie Ramakrishnan-01.01.2021